Inherited abnormalities in the protein C activation pathway

Area of Science:

• Biochemistry
• Molecular Biology
• Hematology

Background:

• The protein C (PC) pathway regulates fibrin formation by activated PC (APC) degrading factors Va and VIIIa.
• PC activation occurs on endothelial cells via thrombin-thrombomodulin (TM) and is enhanced by endothelial cell PC/APC receptor (EPCR).
• Efficient APC generation requires thrombin, TM, PC, and EPCR assembly on endothelial cells.

Purpose of the Study:

• To review known mutations in TM and EPCR genes associated with thrombosis.
• To present a novel strategy for investigating gene mutations in the PC pathway.
• To evaluate this strategy in patients with arterial and venous thrombosis.

Main Methods:

• Review of existing literature on TM and EPCR gene mutations and thrombosis.
• Design and implementation of a new genetic investigation strategy.
• Application of the strategy to analyze TM, EPCR, PC, and prothrombin genes in thrombosis patients.

Main Results:

• Previous studies linked TM and EPCR gene mutations to thrombosis risk.
• No prior studies have directly correlated these mutations with circulating APC levels.
• The new strategy was designed and evaluated for its effectiveness in identifying relevant gene mutations.

Conclusions:

• Dysfunctional PC pathway assembly due to genetic variations can increase thrombosis risk.
• Investigating mutations in TM, EPCR, PC, and prothrombin genes is crucial for understanding thrombosis.
• The developed strategy offers a new approach to identify genetic predispositions to arterial and venous thrombosis.